A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

DR Cornblath, HP Hartung, HD Katzberg, ISJ Merkies, Pieter van Doorn

Research output: Contribution to journalArticleAcademic

10 Citations (Scopus)
3 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)108-114
Number of pages7
JournalJournal of the Peripheral Nervous System
Volume23
Issue number2
DOIs
Publication statusPublished - 2018

Cite this